Alexander A. Seelenberger insider trades: Vincerx Pharma (VINC) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alexander reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | VINC | ↑ Buy | 10,500 | $0.95 | $10K | Direct | Aug 14, 2023 (3d) |
| Dec 22, 2021 | VINC | ↑ Buy | 2,417 | $10.34 | $25K | Direct | Dec 27, 2021 (5d) |
| Jun 29, 2021 | VINC | ↑ Buy | 7,950 | $12.61 | $100K | Direct | Jun 30, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Alexander A. Seelenberger's insider trades
Alexander A. Seelenberger is Chief Financial Officer at Vincerx Pharma (VINC). Since Jun 29, 2021, Alexander has reported 3 open-market purchases worth $135K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VINC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.